Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Blood test identifies women at risk from Alzheimer's

06.11.2009
Middle-aged women with high levels of a specific amino acid in their blood are twice as likely to suffer from Alzheimer's many years later, reveals a thesis from the Sahlgrenska Academy at the University of Gothenburg, Sweden. This discovery this could lead to a new and simple way of determining who is at risk long before there are any signs of the illness.

The thesis is based on the Prospective Population Study of Women in Gothenburg, which was started at the end of the 1960s when almost 1,500 women between the ages of 38 and 60 were examined, asked questions about their health and had blood samples taken. Nearly all of the samples have now been analysed and compared with information on who went on to suffer from Alzheimer's and dementia much later.

"Alzheimer's disease was more than twice as common among the women with the highest levels of homocysteine than among those with the lowest, and the risk for any kind of dementia was 70 per cent higher," says doctor Dimitri Zylberstein, author of the thesis.

Homocysteine is an amino acid that is important for the body's metabolism. It is known that high levels of homocysteine can damage the blood vessels and increase the risk of blood clots. Previous longitudinal studies linking homocysteine and dementia had 8 years of follow-up at most. The present study is by far the longest one with follow-up time of 35 years. The study is also the first to show association between homocysteine levels in middle aged women and dementia development several decades later. The researchers do not yet know whether it is the homocysteine itself that damages the brain, or whether there is some other underlying factor that both increases levels of the homocysteine and causes dementia.

Historically elevated homocysteine levels were related to certain vitamin defficiencies (B12 anf folate). Today we know that high homocysteine levels might be present even with perfectly normal vitamin status. "These days we in our clinical practice use homocysteine analyses mainly for assessment of vitamin status. However, our results mean that we could use the very same analysis för assessment of individual's risk profile for dementia development. This opens the possibility for future preventive treatment at a very early stage", says Zylberstein.

The thesis also looks at a gene which, in some variants, appears to offer protection against dementia. This gene variant reduces the risk of dementia by no less than 65 percent when present doubled (homozygous) which occures in just one in ten Swedes and by 40 percent when present in mixed form (heterozygous) i additional four of ten Swedes.

"We have only been able to carry out a genetic analysis on just over 550 of the blood samples from the Prospective Population Study of Women, and want to undertake bigger studies before we can say for sure that the gene really does protect against dementia," says professor Lauren Lissner who supervised the thesis. "We hope to be able to perform the same analysis on more samples from the study."

The work was carried out in conjunction with the Neuropsychiatric Epidemiology Research Unit as part of EpiLife, the Sahlgrenska Academy's major research project.

DEMENTIA
The most common symptoms of dementia are forgetfulness, impaired speech and problems with recognition and orientation. It is a condition that can affect all our mental faculties and which is more common as we get older. Around seven per cent of the Swedish population over the age of 65 and just over 20 per cent of the over-80s have severe dementia.
For more information, please contact:
Dimitri Zylberstein, registered physician, mobile: +46 705 64 24 01, dimitri.zylberstein@allmed.gu.se
Thesis for a PhD in medicine at the Sahlgrenska Academy, Institute of Medicine, Department of Public Health and Community Medicine

Title of thesis: Homocysteine and vascular morbidity and dementia in women. A prospective population study.

The thesis was successfully defended.

BY: Elin Lindström Claessen
elin.lindstrom@sahlgrenska.gu.se
+46 31-7863869

Helena Aaberg | idw
Further information:
http://www.gu.se/
http://www.sahlgrenska.gu.se

More articles from Health and Medicine:

nachricht Study tracks inner workings of the brain with new biosensor
16.08.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Foods of the future
15.08.2018 | Georg-August-Universität Göttingen

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Color effects from transparent 3D-printed nanostructures

New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference

Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...

Im Focus: Unraveling the nature of 'whistlers' from space in the lab

A new study sheds light on how ultralow frequency radio waves and plasmas interact

Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

LaserForum 2018 deals with 3D production of components

17.08.2018 | Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

 
Latest News

Smallest transistor worldwide switches current with a single atom in solid electrolyte

17.08.2018 | Physics and Astronomy

Robots as Tools and Partners in Rehabilitation

17.08.2018 | Information Technology

Climate Impact Research in Hannover: Small Plants against Large Waves

17.08.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>